What is the latest TATVA stock price?
The latest stored price for TATVA is Rs 1,770.20 as of 2026-09-18.
gimli
TATVA stock AI analysis
TATVA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
TATVA CHIN PHARM CHEM LTD is a small-cap stock in Chemicals. This Gimli page shows the latest available TATVA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹1,770.20
1W return
+6.69%
1M return
+6.03%
3M return
+47.99%
6M return
+50.48%
1Y return
+62.91%
Market cap
₹4,140.87 cr
PE
80.59
PB
5.30
ROE
+6.76%
ROCE
+8.77%
RSI
62.13
Turnover
₹16.28 cr
Why it can matter in screens
- Momentum: TATVA is above 50DMA, above 200DMA; RSI is 62.13.
- Returns: 1D +3.54%, 1W +6.69%, 1M +6.03%, 3M +47.99%, 1Y +62.91%.
- Trend levels: 52W high ₹1,838.10, 52W low ₹1,101.00, off high -3.69%.
- Liquidity: latest turnover is ₹16.28 cr; volume vs 20D is +1.60%.
- Valuation/profitability: PE 80.59, PB 5.30, ROE +6.76%, ROCE +8.77%.
- Growth: 3Y sales CAGR +6.32%, 3Y profit CAGR -2.59%.
Quick Answers
Is TATVA above its 50DMA and 200DMA?
TATVA is above 50DMA, above 200DMA. The latest 50DMA is 1,648.34 and the latest 200DMA is 1,349.23.
What are TATVA PE, ROE and ROCE?
TATVA has PE 80.59, ROE +6.76%, and ROCE +8.77% in Gimli's latest available snapshot.
How has TATVA performed recently?
TATVA has returned +6.03% over 1 month, +47.99% over 3 months, and +62.91% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 167.06 cr | 33.76 cr | 15.98 cr | 6.83 |
| 2026-03-31 | 134.14 cr | 27.78 cr | 10.32 cr | 4.41 |
| 2025-12-31 | 131.33 cr | 27.22 cr | 15.16 cr | 6.49 |
| 2025-09-30 | 123.52 cr | 23.22 cr | 9.92 cr | 4.24 |
| 2025-06-30 | 116.86 cr | 18.48 cr | 6.65 cr | 2.84 |
| 2025-03-31 | 107.86 cr | 9.67 cr | 1.03 cr | 0.44 |
| 2024-12-31 | 85.90 cr | 7.10 cr | 0.14 cr | 0.06 |
| 2024-09-30 | 83.49 cr | 5.96 cr | n/a | -0.29 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 505.86 cr | 96.71 cr | 42.05 cr | 17.98 |
| 2025-03-31 | 382.71 cr | 36.53 cr | 5.71 cr | 2.44 |
| 2024-03-31 | 390.50 cr | 75.32 cr | 30.35 cr | 13.26 |
| 2023-03-31 | 420.89 cr | 62.33 cr | 45.49 cr | 20.52 |
| 2022-03-31 | 438.44 cr | 116.65 cr | 95.99 cr | 44.59 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 1,003.69 cr | 5.76 cr | 120.37 cr | 781.76 cr |
| 2025-03-31 | 836.25 cr | 11.37 cr | 36.39 cr | 738.82 cr |
| 2024-03-31 | 818.72 cr | 35.30 cr | 14.27 cr | 737.08 cr |
| 2023-03-31 | 758.86 cr | 27.36 cr | 170.26 cr | 514.79 cr |
| 2022-03-31 | 658.05 cr | 63.02 cr | 119.94 cr | 473.09 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 31.49 cr | -82.28 cr | n/a |
| 2025-03-31 | 24.77 cr | -51.50 cr | n/a |
| 2024-03-31 | 98.04 cr | -30.47 cr | n/a |
| 2023-03-31 | 27.78 cr | -175.33 cr | n/a |
| 2022-03-31 | 20.23 cr | -68.93 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +72.02% | +3.93% | +3.11% | +2.79% | +20.94% | +0.00% |
| 2026-03-31 | +72.02% | +3.82% | +2.99% | +2.87% | +21.17% | +0.00% |
| 2025-12-31 | +72.02% | +4.17% | +3.33% | +3.25% | +20.48% | +0.00% |
| 2025-09-30 | +72.02% | +3.39% | +3.86% | +3.82% | +20.73% | +0.00% |
| 2025-06-30 | +72.02% | +3.26% | +5.11% | +5.07% | +19.60% | +0.00% |
| 2025-03-31 | +72.02% | +3.30% | +5.46% | +5.34% | +19.22% | +0.00% |
| 2024-12-31 | +72.02% | +3.36% | +6.34% | +6.26% | +18.28% | +0.00% |
| 2024-09-30 | +72.02% | +3.33% | +6.82% | +6.76% | +17.82% | +0.00% |
| 2024-06-30 | +72.02% | +3.37% | +10.63% | +10.60% | +13.98% | +0.00% |
| 2024-03-31 | +72.02% | +3.65% | +12.84% | +12.84% | +11.49% | +0.00% |
| 2023-12-31 | +72.02% | +4.21% | +13.06% | +13.05% | +10.71% | +0.00% |
| 2023-09-30 | +72.02% | +4.41% | +13.79% | +13.54% | +9.78% | +0.00% |
| 2023-08-29 | +75.02% | +4.13% | +13.85% | +13.57% | +7.00% | +0.00% |
| 2023-06-30 | +79.17% | +3.19% | +11.07% | +10.76% | +6.56% | +0.00% |
| 2023-03-31 | +79.17% | +3.54% | +11.71% | +10.98% | +5.58% | +0.00% |
| 2022-12-31 | +79.17% | +3.74% | +11.52% | +11.12% | +5.57% | +0.00% |
| 2022-09-30 | +79.17% | +3.59% | +11.16% | +10.80% | +6.08% | +0.00% |
| 2022-06-30 | +79.17% | +0.00% | +14.28% | n/a | n/a | +0.00% |
| 2022-03-31 | +79.17% | +0.00% | +11.18% | n/a | n/a | +0.00% |
| 2021-12-31 | +79.17% | +0.00% | +10.78% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 167,904.38 cr | 84.314744 | +35.93% | +26.94% |
| PIDILITIND | PIDILITE INDUSTRIES LTD | 160,004.45 cr | 60.281452 | +25.27% | +2.95% |
| SRF | SRF LTD | 74,457.19 cr | 34.443333 | +16.21% | -14.49% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 58,928.92 cr | 32.377284 | +14.95% | -13.24% |
| LINDEINDIA | LINDE INDIA LIMITED | 53,230.13 cr | 96.965414 | +13.58% | -3.17% |
| FLUOROCHEM | GUJARAT FLUOROCHEM LTD | 50,384.90 cr | 87.171106 | +7.60% | +23.51% |
| FACT | FACT LTD | 49,449.24 cr | -1248.718238 | -2.91% | -22.73% |
| UPL | UPL LIMITED | 48,961.82 cr | 23.550659 | +5.26% | -17.02% |
Try these prompts
- Analyze TATVA CHIN PHARM CHEM with valuation, momentum and industry peers
- Compare TATVA with other Chemicals stocks
- Show small-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare TATVA with other Chemicals stocks
Data snapshot: 2026-09-18. Not investment advice.